Tuberculosis prevention must integrate technological and basic care innovation

Eur Respir J. 2016 Nov;48(5):1531-1532. doi: 10.1183/13993003.01601-2016.

Authors

Heidi Albert¹, Ruvandhi R Nathavitharana², Claudia M Denkinger³, Chris Isaacs³, Catharina C Boehme³

Affiliations

¹ Foundation for Innovative New Diagnostics, Cape Town, South Africa heidi.albert@finddx.org.
² Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
³ Foundation for Innovative New Diagnostics, Geneva, Switzerland.

PMID: 27799403
DOI: 10.1183/13993003.01601-2016

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Tuberculosis*